Telomerase expression by aberrant methylation of the TERT promoter in melanoma arising in giant congenital nevi

Journal of Investigative Dermatology

Volumn 136, Issue 1, 2016, Pages 339-342

  Fan, Yiping ^a   Lee, Seungjae ^a   Wu, Gang ^a   Easton, John ^a   Yergeau, Donald ^a   Dummer, Reinhard ^b   Vogel, Peter ^a   Kirkwood, John M ^c   Barnhill, Raymond L ^d   Pappo, Alberto ^a   Bahrami, Armita ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; TERT PROTEIN, HUMAN;

CONGENITAL NEVUS; CPG ISLAND; DNA METHYLATION; ENZYME ACTIVITY; GENE EXPRESSION; GENE MUTATION; GIANT CONGENITAL NEVUS; HUMAN; LETTER; MELANOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RNA SEQUENCE; TRANSCRIPTION INITIATION SITE; CELL TRANSFORMATION; EPIDEMIOLOGY; EPIGENETICS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; MALE; NEEDLE BIOPSY; NEVUS, PIGMENTED; PATHOLOGY; PROGNOSIS; SKIN NEOPLASMS; UPREGULATION;

BIOPSY, NEEDLE; CELL TRANSFORMATION, NEOPLASTIC; DNA METHYLATION; EPIGENOMICS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; NEVUS, PIGMENTED; PROGNOSIS; PROMOTER REGIONS, GENETIC; SAMPLING STUDIES; SKIN NEOPLASMS; TELOMERASE; UP-REGULATION;

EID: 84959566355     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/JID.2015.374     Document Type: Article

References (15)

1. Bell RJ, Rube HT, Kreig A, et al. Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer. Science 2015;348:1036-9.
2. Bittencourt FV, Marghoob AA, Kopf AW, et al. Large congenital melanocytic nevi and the risk for development of malignant melanoma and neurocutaneous melanocytosis. Pediatrics 2000;106:736-41.
3. Blackburn EH. Structure and function of telomeres. Nature 1991;350:569-73.
4. Castelo-Branco P, Choufani S, Mack S, et al. Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study. Lancet Oncol 2013;14:534-42.
5. Guilleret I, Benhattar J. Demethylation of the human telomerase catalytic subunit (hTERT) gene promoter reduced hTERT expression and telomerase activity and shortened telomeres. Exp Cell Res 2003;289:326-34.
6. Guilleret I, Benhattar J. Unusual distribution of DNA methylation within the hTERT CpG island in tissues and cell lines. Biochem Biophys Res Commun 2004;325:1037-43.
7. Horn S, Figl A, Rachakonda PS, et al. TERT promoter mutations in familial and sporadic melanoma. Science 2013;339:959-61.
8. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266: 2011-5.
9. Lee S, Barnhill RL, Dummer R, et al. TERT promoter mutations are predictive of aggressive clinical behavior in patients with spitzoid melanocytic neoplasms. Sci Rep 2015;5:11200.
10. Lu C, Zhang J, Nagahawatte P, et al. The genomic landscape of childhood and adolescent melanoma. J Invest Dermatol 2015;135:816-23.
11. Renaud S, Loukinov D, Abdullaev Z, et al. Dual role of DNA methylation inside and outside of CTCF-binding regions in the transcriptional regulation of the telomerase hTERT gene. Nucleic Acids Res 2007;35: 1245-56.
12. Vinagre J, Almeida A, Populo H, et al. Frequency of TERT promoter mutations in human cancers. Nat Commun 2013;4:2185.
13. Xu M, Katzenellenbogen RA, Grandori C, et al. An unbiased in vivo screen reveals multiple transcription factors that control HPV E6-regulated hTERT in keratinocytes. Virology 2013;446: 17-24.
14. Yelamos O, Arva NC, Obregon R, et al. A comparative study of proliferative nodules and lethal melanomas in congenital nevi from children. Am J Surg Pathol 2015;39:405-15.
15. Zinn RL, Pruitt K, Eguchi S, et al. hTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site. Cancer Res 2007;67: 194-201.